Methylation | Gene | Model | Role in TC | Reference |
---|---|---|---|---|
Hypermethylation | RASSF1A | Human TC cell lines and primary thyroid tumor samples from patients, including both benign and malignant tumors. | Regulating cell cycle and apoptosis | [19] |
Hypermethylation | P16 | 74 PTC samples and 21 adjacent normal thyroid tissues | disrupting cell cycle control | [20] |
Hypermethylation | TIMP3 | Thyroid Tumor Samples: The cohort included 44 thyroid cancer samples and 44 benign thyroid lesions. Adjacent Normal Thyroid Tissue: Additionally, 15 samples of adjacent normal thyroid tissue were examined. | Inhibiting invasion and metastasis by inhibiting MMPs | [21] |
Hypermethylation | ATF3 | Cell Lines: The study employed thyroid cancer cell lines to investigate the effects of ATF3 silencing and its subsequent impact on gene expression and pathway regulation. Clinical Samples: Tumor tissues from patients with thyroid cancer were used to analyze the methylation status of the ATF3 gene. These samples helped establish the correlation between ATF3 methylation and the progression of thyroid cancer. | Inhibiting the proliferation and migration of TC cells | [22] |
Hypermethylation | OGG1 | Malignant thyroid tissues from patients with PTC | Impairing the BER pathway | [23] |
Hypermethylation | ATM | Thyroid Tumor Samples: The cohort included 44 thyroid cancer samples and 44 benign thyroid lesions. Adjacent Normal Thyroid Tissue: Additionally, 15 samples of adjacent normal thyroid tissue were examined. | Impairing DNA repair mechanisms | [21] |
Hypermethylation | TSHR | Tissue samples from patients diagnosed with TC | Associated with the MAPK pathway | [24] |
Hypomethylation | MAP17 | Various subtypes of thyroid tumors, including papillary, follicular, medullary, and anaplastic thyroid cancers | Promoting tumor growth | [25] |
Hypomethylation | CTLA-4 | Peripheral blood samples from 200 patients with TC and 200 healthy controls. | Enhancing evasion of immune surveillance | [26] |
Hypomethylation | MAP17 | Human PTC cell lines, Tumor tissues from patients with PTC and Xenograft models | Promoting EMT | [27] |
Hypomethylation | TERT | Human PTC cell lines and Tumor tissues from patients with PTC | Correlating with poorer prognosis | [28] |